I see you as a poster on both ihub and stockhouse...few points if you don't mind...
1) That stockhouse board is toxic, very toxic, lol seems many personal issues and battles getting in way of intelligent discussion...but what do I know..
2) the OSC review is a weird one. There are so many other publicly listed companies that provide projections based on specific criteria and yet I don't see PRs like last night's by them. OSC is known to hit the smaller companies hardest. I don't get it. I say this because if you read the referred to earlier PRs (3 of them), and especially the most recent ones in May, they actually do already mention many of the same disclosures downplaying the company and speaking to it's short term issues...I would guess so in line with NI 51-102. So I guess I'm confused why this additional disclosure was necessary other than for some other reason. the PR last night seems like repackaging of earlier PRs and I don't get why it was necessary other than for some bigger reason. If anything it was overkill, and now conservatively repositions the company.
3) I find it weird that within the last month the financials were released where it was pretty evident that the $10m for 2017 was not going to be met, and again they disclosed many of the same comments then as last night, and the PPS seemed to be adjusted accordingly. So I guess what I'm saying here is that is it possible most of the news last night is "baked in"
3) if you read thru last nights PR, yes they do say that they won't hit their previous projections. But it doesn't speak to any updated projections. Their business isn't going to zero. Their business still has a product with HC and FDA approval. They still have patents, etc
Anyway, just wanted to get some points out and I saw you posting to both boards
